Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

detoxification · Mechanism Report

Does the GSTP1 rs1695 AG genotype alter glutathione-conjugation activity?

The GSTP1 rs1695 AG genotype produces the Ile105Val enzyme variant and can change glutathione-conjugation activity in a substrate-dependent way.

PlausibleSeptember 14, 20268 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

The GSTP1 rs1695 AG genotype changes the Ile105Val enzyme and can alter glutathione-conjugation activity in a substrate-dependent manner.

laying out figure…
2 of 4 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

This claim says the AG genotype encodes a GSTP1 Ile105/Val105 heterozygous enzyme state rather than a single uniform protein form. The mechanism is framed as a structural change in the enzyme’s substrate-binding region, which can shift conjugation activity and stability depending on the substrate involved. It does not imply the same direction of effect for all compounds.

Verified conclusion

GSTP1 rs1695 is a common coding variant with a well-established biochemical consequence: the AG genotype encodes the Ile105/Val105 heterozygous state. Its relevance is enzymatic rather than a uniform prediction of detoxification capacity or clinical outcome.

Molecular and functional evidence

  • rs1695 is c.313A>G: the A allele encodes Ile105 and the G allele Val105. Thus, AG carriers are expected to express both Ile105- and Val105-containing GSTP1 subunits.
  • Purified recombinant allozymes show altered glutathione-conjugation kinetics, including substrate affinity, turnover, and catalytic efficiency. In human lung cytosol, CDNB-conjugating activity in Ile/Val individuals was intermediate (62.1 ± 4.2 nmol·mg⁻¹·min⁻¹) between reported Ile/Ile and Val/Val activity.

Substrate-specific mechanism

  • Ile105Val remodels the enzyme’s hydrophobic substrate-binding H-site, altering pocket geometry, hydrophobicity, and steric accommodation. The glutathione-binding G-site is not the principal affected region.
  • With CDNB, Val105-containing enzyme had a higher Km than Ile105 (1.15 vs 0.33 mM in Ala114-background proteins), consistent with lower apparent substrate affinity and reduced catalytic efficiency.
  • This is not a universal loss of function: Val105 can show greater activity toward ethacrynic acid and substantially greater efficiency toward some polycyclic-aromatic-hydrocarbon diol epoxides.

Additional biochemical consideration

  • Val105-containing GSTP1 is reported to be approximately two- to threefold less thermally stable than the Ile105 form, which could further influence enzyme performance under particular experimental or cellular conditions.

Bottom line

  • The claim is supported: rs1695 AG produces the GSTP1 Ile105/Val105 variant state, and the substitution can alter glutathione conjugation. Its effect is substrate-dependent—potentially lower for some electrophiles and higher for others—so AG should not be interpreted as globally reduced or increased GSTP1 function.

References

  1. NM_000852.4(GSTP1):c.313A>G (p.Ile105Val) AND fluorouracil ... — ncbi.nlm.nih.gov ↗
  2. Evaluating the role of GSTP1 genetic polymorphism (rs1695 ... — pmc.ncbi.nlm.nih.gov ↗
  3. Carcinogenesis vol.19 no.2 pp.275–280, 1998 — citeseerx.ist.psu.edu ↗
  4. Variants of glutathione s-transferase pi 1 exhibit differential ... — pmc.ncbi.nlm.nih.gov ↗
  5. Structure-activity relationships and thermal stability of ... — pubmed.ncbi.nlm.nih.gov ↗
  6. GSTP1 Ile105Val (rs1695) — GeneOps — geneops.ai ↗
  7. Gene Sequence Variation and Functional Genomic Studies — pmc.ncbi.nlm.nih.gov ↗
  8. The Role of Glutathione S-transferase P in signaling pathways and ... — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible12 sourcesDo metals and mycotoxins increase demand on glutathione-dependent antioxidant and detoxification pathways?→Plausible5 sourcesDo multiple urinary metal elevations suggest cumulative exposure and clearance burden?→